Pete (pictured right), an RCVS Recognised Specialist in Veterinary Dentistry, was recognised for his outstanding contributions to the discipline of veterinary oral and maxillofacial surgery (OMFS).
There are a total of 14 founding fellows and Pete is the only one practising in Europe. The award will mean it’s possible for an OMFS Fellowship programme to be delivered at Eastcott Referrals in the future.
Pete said: "To be accepted as an AVDC Fellow is a real honour and I’m delighted to be awarded this position. There is a pretty rigorous process to go through to become a Founding Fellow of the AVDC, so it’s extremely gratifying to be recognised."
At the same time, another Eastcott clinician is also celebrating recognition in the same discipline: Andrew Perry has become a European Veterinary Specialist in Dentistry.
Pete said: "We all congratulate Andrew on his achievement. He is a hugely valuable and experienced member of the team here.
"It’s a very exciting time for Eastcott, as we seek to expand our dentistry and oral and maxillofacial surgery department and develop new techniques in OMFS.
"We have a highly experienced team and will adding another Resident in the new year, so we’re in an extremely strong position to deal with a large caseload and able to see a wide range of different cases."
For more information about Eastcott Referrals, visit www.eastcottreferrals.co.uk.
The company says the two main benefits of the liquid formulation are precise dosing and ease of administration.
Vetmedin oral solution comes with a kg-bodyweight calibrated syringe to make it easy to give the preferred dose of 0.25 mg/kg twice daily to the nearest 0.5 kg bodyweight.
The maximum syringe volume is for a 12 kg dog.
The solution has a sweet taste to make it palatable and Boehringer says it is also ideal for dogs that need dental work but require treatment for their heart disease before general anaesthesia.
These dogs might struggle to eat chewable tablets due to oral discomfort, so a liquid treatment might be a better option.
The company highlights the EPIC1 and PROTECT2 studies which showed that Vetmedin delays the onset of CHF for dogs in the asymptomatic stage of heart disease and improves both the quality and length of life for dogs with MVD and DCM.
Vetmedin oral solution comes as a 50 ml bottle (each bottle lasts a 5 kg dog approximately 30 days), doesn't need to be refrigerated, has an 8-week shelf life once opened, and a 2-year shelf life as packaged.
VetMedin oral solution is now available to order from wholesalers.
References
PBD says Bovine tuberculosis (bTB) is a growing problem for zoos and wildlife parks, especially with the disease’s potential to spread from one species to another, creating a natural reservoir that is difficult to control.
bTB in zoos came to public attention last year when Devon’s Paignton Zoo detected a single case in one of its antelope. Without access to a test that would deliver rapid results, the zoo had to cull the remaining 10-strong herd of Kafue Flats lechwe.
PBD says the Actiphage test can identify bTB and other mycobacterial diseases in animals before clinical symptoms of infection are observed. It can detect with high specificity the presence of any mycobacteria in animal blood within 6 hours in comparison to culturing mycobacteria, which can take up to 12 weeks.
The technology has been successfully applied to blood samples from 17 different species so far, including deer, goats and badgers as well as exotic animals such as lions, giraffes, antelopes, elephants, tigers, kangaroos and camels. Trials have confirmed PBD Biotech’s assay can detect live mycobacteria in blood or milk samples at very high sensitivity, of less than 10 mycobacterial cells per ml of sample.
The test is being presented to delegates at the British Veterinary Zoological Society (BVZS) Congress in Birmingham today by Dr Ben Swift, Research Fellow at the Royal Veterinary College and R&D Director at PBD Biotech.
He said: "The Actiphage detection method provides a major step change in the detection of viable mycobacteria and has the potential to revolutionise the control and understanding of mycobacterial diseases in zoo animals, wildlife and a range of other species.
"The use of bacteriophage means the test can detect mycobacteria before an immune response is fully developed, giving vets, zoo-keepers and other exotics experts a head-start on the race to catch bTB and other diseases in the hope of preventing the unnecessary cull of protected animals."
The new bill - Animal Welfare (Sentencing and Recognition of Sentience) - would increase the maximum prison sentence for animal cruelty tenfold, from six months to five years, in England and Wales.
The draft bill also sets out that the government "must have regard to the welfare needs of animals as sentient beings in formulating and implementing government policy".
Subject to consultation on the draft bill, the government says it will legislate to deliver both aims.
In fact, the draft bill goes further than Article 13 as it applies to all areas of government policy, rather than specified areas of policy. If passed, the law would apply to the whole of the UK.
Environment Secretary Michael Gove said: "Animals are sentient beings who feel pain and suffering, so we are writing that principle into law and ensuring that we protect their welfare. Our plans will also increase sentences for those who commit the most heinous acts of animal cruelty to five years in jail. We are a nation of animal lovers so we will make Brexit work not just for citizens but for the animals we love and cherish too."
BVA President John Fishwick said: "Vets have been clear in our calls that the duty on the state to have due regard for animal welfare - as captured in Article 13 of the EU Lisbon Treaty - must be enshrined in UK law. This Bill captures the substantive obligation that Article 13 currently puts on the national government to consider animal welfare, as well as explicitly recognising animals as sentient beings."
"Today’s draft Bill lays out in black and white the Government making good on its promises, to ensure the UK remains a global leader in animal welfare post-Brexit."
To mark today's European Antibiotic Awareness Day 2010, the British Veterinary Association is warning veterinary surgeons in the UK that failure to use antimicrobials responsibly could result in their use being restricted.
The BVA promotes the responsible use of antimicrobials and last year published a poster and guidance for vets: 'Responsible use of antimicrobials in veterinary practice: the 8-point plan'. According to the association, the poster received very positive feedback from across the UK and from the Federation of Veterinarians of Europe (FVE).
Concerns regarding resistance to antimicrobials and antibiotics span both the human and animal medicine fields and in 2008 the Chief Medical Officer called for a ban on the use of certain types of antibiotics in animals in order to protect their activity in humans.
Furthermore some EU Member States already restrict the availability of antimicrobials to veterinary surgeons and adopt a strict formulary approach to the medicines that they can prescribe. The BVA says it is concerned that this trend will reach the UK and the freedom of vets to prescribe according to their clinical judgement will be restricted.
Harvey Locke, President of the BVA, said: "Antimicrobial resistance is an enormous problem for both human and animal health. As veterinary surgeons we have a duty to use these medicines responsibly for the good of animal health and welfare as well as public health.
"The BVA's poster on responsible use should be displayed in veterinary practices across the UK as a constant reminder, and I would urge all vets to refer to it.
"Failure to heed the message of responsible use could result in vets losing the right to prescribe certain medicines, which could have a significant impact on animal health and welfare.
"On Antibiotic Awareness Day our message to vets is clear: use them responsibly or lose them."
Vetoquinol is launching Forcyl, an injectable anti-infective for the targeted therapeutic treatment of respiratory infections in cattle, in November.
Forcyl is a patented 16% marbofloxacin solution, registered as a single intramuscular injection, which the company says will ensure a high level of compliance.
Forcyl follows the SISAAB concept (single injection short acting antibiotic), with an optimised dosage to minimise the risk of development of antibiotic resistance. Shorter exposure time limits the opportunity for resistance to develop. The formulation means a lower volume of administration (10 ml for 160 kg body weight) is required. Vetoquinol says that other benefits of Forcyl include excellent injection site tolerance and short withdrawal periods (meat: 5 days, milk: 48 hours).
For further information on implementing the SISAAB concept in your practice, please contact one of Vetoquinol's large animal team on 01280 814500.
Boehringer Ingelheim Vetmedica has extended its Metacam 0.5 mg/ml Oral Suspension for Cats range with the launch of a 30ml bottle size, which the company says will last the average 5 kg cat for two months.
According to Boehringer, the new 30ml bottle will offer owners a cost saving compared to purchasing two 15 ml bottles. In addition, it will provide greater prescription options for veterinary practices currently stocking 3ml and 15 ml bottles,,
Andrew Francis, Metacam brand manager said: "The new 30ml bottle of Metacam Oral Suspension for Cats will provide both veterinary practices and their clients with a product that is great for the long-term treatment of chronic pain in cats in one convenient pack."
For further information on Metacam, contact your local Boehringer Ingelheim Vetmedica territory manager or telephone 01344 746959.
According to statistics from the RCVS, almost 40% of veterinary surgeons that have registered in the UK since 2005 qualified from veterinary schools elsewhere in the EU.
Of course, it's not just in general practice that veterinary surgeons and veterinary nurses from other EU member states make such an important contribution. They work across all areas of veterinary science, including the fields of animal health and welfare, animal disease surveillance, scientific research and education, wildlife conservation, and public health and food safety.
Figures from the Veterinary Public Health Association (VPHA) estimate that over 90% of vets in meat hygiene services are non-British EU citizens.
To highlight the impact of Brexit on the veterinary profession, the BVA has written to the Secretary of State, Liz Truss MP, and to Ministers in Scotland, Wales and Northern Ireland, requesting an early statement to the effect that non-British EU vets and vet nurses who are currently living, studying or working in the UK will continue to be able to do so in future.
BVA is also seeking reassurance for UK veterinary professionals working and studying in other EU member states.
BVA President Sean Wensley said: "It is not yet possible to comment on the reality of ‘Brexit’ since much will depend on forthcoming negotiations and the decisions that will be taken by the Government regarding, for example, whether or not to maintain existing EU legislation and rules. However, we recognise that these unanswered questions are having a profound impact on many of our members – particularly members who are non-British EU citizens, or have family members who are, and members who work alongside colleagues from other European Member States."
In the letters, Mr Wensley wrote: "I am sure there are many significant issues that your Department needs to consider [and] given the profound personal impact that the uncertainty caused by the referendum outcome is having on some of our members, we wanted to contact you at the earliest opportunity. In the forthcoming negotiations about the future relationship between the UK and the EU, we strongly urge you to make the case for all EU citizens and EU-qualified veterinary surgeons and nurses to have ongoing rights to live, work and study in the UK."
In the letter to the Northern Ireland (NI) Minister of Agriculture, Environment and Rural Affairs Michelle McIlveen MLA, the BVA President and BVA NI Branch President Seamus O’Kane highlighted NI’s land border with EU member state the Republic of Ireland and called for the maintenance of the Common Travel Area to facilitate movement in an all-island context for both work and study purposes.
VPHA President Lewis Grant said: "Due to the particular focus on public health in many European veterinary degree courses, EU vets make an enormous contribution to both public health and animal health and welfare in the UK - often behind closed doors, monitoring and protecting public health in Approved Premises as well as welfare at slaughter to ensure slaughterhouses meet the standards that are required by law and expected by the public. Without their input and expertise, it would be difficult to ensure that Statutory requirements within the food industry are complied with."
Is it right to keep treating an animal just because the technology is available? This is a question that Noel Fitzpatrick, aka the BBC's Bionic Vet, will be addressing at this year's British Veterinary Association (BVA) Congress, in a debate titled 'Treatment too far?' on Friday 24th September at 4pm.
The BVA Congress will take place in the Glasgow Marriott Hotel on 23-25 September 2010 under the theme 'Vets and the Public Good', looking at the role of veterinary surgeons in all aspects of society.
Organisers say that Congress will be a truly Scottish event, led by BVA President Professor Bill Reilly (born and bred in Glasgow and a graduate of Glasgow Vet School) with clinical CPD sessions delivered by Scotland's finest research and academic institutions.
This year also boasts a full non-clinical stream of lectures tackling employment law, management skills, and mental health.
Highlights include:
Vets and the public good: the broader perspective (Wooldridge Memorial Lecture)Professor Stuart Reid, Dean of the Faculty of Veterinary Medicine at the University of Glasgow will deliver the keynote Wooldridge Memorial Lecture. He will consider the extent of the veterinary contribution to society, which extends into areas such as public health, infectious disease control, scientific research, public education, food production, national security, disaster management, care of the environment, and international development. (Fri 24 Sept, 12.15-13.25)
Pets and society: turning a blind eye to abuse?It is nearly a decade since attention began to be drawn to evidence of links between animal abuse and domestic violence towards humans. This session will examine the dilemmas confronting practising vets, asking at what stage should suspicions of abuse be reported and to whom? (Fri 24 Sept, 11.00-12.00)
Four into one must go Following last year's highly popular session, the UK's four CVOs will again come together to debate and discuss current issues in veterinary politics and animal health and welfare, under the chairmanship of BVA President Professor Bill Reilly. (Sat 25 Sept, 9.30-10.30)
Responsibility and cost sharing - where are we now? This session will include a progress report from Rosemary Radcliffe, chair of the independent committee that will be advising the Government on establishing new arrangements in England, and a discussion of what this might mean for practising vets. (Sat 25 Sept, 16.00-17.00)
In addition there will be contentious issue debates on the role of vets in promoting farm animal welfare, the practical difficulties of current dangerous dogs legislation, and the role of vets as experts witnesses in cases of abuse or neglect.
Under the theme of 'public good' there will be a session looking at the role of vets in international development 'Improving the livelihoods of farmers in resource-poor countries', and a session on the zoonotic infections that impact on public health, such as E. Coli and Chlamydia, and what organisations like open farms can do to minimise the risks.
Professor Bill Reilly, President of the BVA, said: "Vets and the public good has been the theme of my presidential term because I believe that the role of vets in all aspects of society should receive more attention.
"Our Congress programme combines the world-renowned expertise of Scotland's academic and research institutes with significant topical issues of debate to capture the widest possible definition of the veterinary contribution to society."
For more information on BVA Congress 2010 (including the full agenda and online registration) visit the BVA website www.bva.co.uk/congress
Neurodiversity Celebration Week is a worldwide initiative that challenges stereotypes and misconceptions about neurological differences, and the neurodiversity resource hub (www.vetmindmatters.org/resources/) aims to help members of the veterinary professions better understand how, for over one million people in the UK, neurological differences mean they learn and think in a way that is different to what is considered ‘neurotypical’.
Among the resources contained in the hub is information about neurological conditions closely associated with neurodivergence such as attention deficit hyperactivity disorder (ADHD), autism, dyspraxia and dyslexia, as well as information for employers about neurodiversity, including inclusive working tools and sources of government support.
A new ‘kite’ with six new modules are also being added to the MMI Kite App – a specialist microlearning platform for topics related to veterinary wellbeing – that deal specifically with issues related to neurodiversity. The six modules cover: what is neurodiversity; the importance of talking about neurodiversity; different types of neurodiversity; bespoke considerations for neurodivergent individuals; how neurodivergence can lead to innovation through thinking differently; and, exploring further how different brains work and how we can make our brains work best for us.
The College is also publishing a blog on the resource website by Dr Kirstie Pickles, Clinical Assistant Professor in Equine Medicine at the University of Nottingham, about her current MMI-funded research investigating the various workplace stressors that affect autistic veterinary professionals and what adjustments can be introduced to mitigate these stressors.
Lastly, at BSAVA Congress on Saturday 26 March between 3pm and 4pm, the RCVS has organised a discussion session on neurodiversity.
The discussion will be led by Roxanne Hobbs, a consultant in workplace inclusion particularly around neurodiversity, and will look at how to nurture and cultivate neurodiversity in the veterinary professions.
Lisa Quigley, Mind Matters Manager, said: “As a project focused on the mental health and wellbeing of veterinary professionals, the Mind Matters project has a commitment to recognising and providing a space for all forms of diversity, and so we are very glad to be supporting Neurodiversity Celebration Week again this year.
“We hope that our neurodiversity resource hub and our other initiatives during Neurodiversity Celebration Week will be useful source of information for everyone and will aid people in understanding neurodivergence, how it can manifest and how it can be supported in the workplace and educational settings.”
The new service is led by Virginia Crespo DVM PGDip MSc MRCVS and Alex Hamilton BA VetMB MRCVS, pictured right.
Virginia qualified in 2012 from the Autonomous University of Barcelona, where she also served a rotating internship before completing an internship in neurology and neurosurgery at the Animal Health Trust in 2016. She finished a three-year residency in neurology and neurosurgery at Langford Veterinary Services in July, alongside attaining a Master’s of Science degree with Bristol University.
Alex graduated from Cambridge University in 2005 and after five years working in both mixed and emergency and critical care practice, he completed a surgical internship at the Animal Referral Hospital, Sydney, in 2012. He then completed a European accredited neurology residency at Melbourne University and Willows Veterinary Centre, in Solihull, and has since worked in Australia and the UK as a neurologist.
Clinical director Duncan Barnes said: “We’re delighted to welcome Virginia and Alex to Eastcott to lead this new service.
"They will provide in-depth consultations and neurological assessments alongside a variety of advanced diagnostic procedures to identify the problem and prepare an appropriate treatment plan.
"Virginia and Alex will have access to Eastcott’s new 1.5T MRI scanner and the clinic’s CT scanner, as well as electromyography, to assess the function of the nerves and muscles, and cerebrospinal fluid analysis.
"They will also work closely with another new recruit, Nicholas Taylor, who has joined us as referral radiographer, and other specialists across the hospital as part of a holistic approach to patient care."
For more information visit www.eastcottreferrals.co.uk.
Virbac has launched a new 12 month version of Suprelorin, the reversible medical castration implant for dogs, widening the options for clients seeking an alternative to surgical castration.
Product manager Chris Geddes MRCVS said: "The launch of Suprelorin 12 gives practices the chance to offer dog owners a more convenient castration option. The implant renewal can now be included with their dog's annual boosters or health check.
"The slow-release implant is inserted at the back of the neck in the same manner as a microchip. There is no anaesthetic, no surgery and no scarring. The current implant, which contains 4.7mg active and lasts for around 6 months after insertion, will continue to be available for those wanting a more brief solution or as a trial.
"Deslorelin is a GnRH superagonist which causes suppression of LH/FSH, and therefore testosterone production, leading to temporary infertility."
For further information on Suprelorin/12, please call and ask to speak to one of our veterinary advisors on 01359 243243, or contact your local Virbac territory manager.
Prior to joining Fitzpatrick Referrals, Gerard was a Senior Lecturer in Internal Medicine at the University of Glasgow as well as Head of the Emergency Service and Director of both the Internship and ECVIM Residency Programmes. He is also a European and Royal College Recognised Specialist in Internal Medicine, and recently became one of few specialists in the world to have completed a 12 month Fellowship in Interventional Radiology at the Animal Medical Center in New York.
Gerard said: "When I returned to the UK, it was a natural fit for me to join Fitzpatrick Referrals. The team all share the same ethos and together I know we will be able to offer a truly world-class service to our patients and their family. I genuinely believe we will be able to change what is accepted as the gold standard of care for animals in the UK."
Fitzpatrick Referrals says its interventional radiology service performs minimally invasive procedures that are often considered the standard of care in human medicine, providing options for veterinary patients where conventional therapies are not associated with the best outcome.
Clinical Director of Oncology and Soft Tissue, Professor Nick Bacon said: "Gerard joining the team in Guildford opens new doors for our patients but more importantly we hope the disciplines of veterinary oncology and soft tissue surgery as a whole. He brings huge experience in interventional radiology solutions for portosystemic shunts, tracheal collapse and urinary calculi obstruction. Gerard is also key to developing our cancer care. Progress is not about ever bigger treatments chasing a cure; it can just as easily mean delivering palliative or curative-intent treatments in smarter ways, with less side-effects and lower morbidity. I am looking forward to watching our treatments evolve for a variety of tumours including urinary, liver, lung and head and neck. No cancer treatment is perfect, but we are striving for the best we can for the patient in front of us."
Noel Fitzpatrick said: "It remains my objective to build the greatest team of super-specialists on planet earth where we can offer all of the options to all of the animals and the families that love them all of the time. Gerard has a unique skill set that will not only complement our growing team, but will enhance the spectrum of treatments we can offer and which the families of animals throughout the UK and beyond really want. Increasingly people want the same level of care for their dogs and cats as we have for ourselves and our goal is to deliver exactly that with the very best team and facilities in the world today."
Fitzpatrick Referrals will be holding a Partners in Care CPD session on 25th May inviting vets to meet Dr Gerard McLauchlan and discover more about the interventional radiology service. To register your interest, contact Sarah on SarahC@fitzpatrickreferrals.co.uk.
Virbac has announced the launch of Carprox Vet, a carprofen-based NSAID indicated for the alleviation of post-operative pain and inflammation following orthopaedic and soft tissue surgery in dogs and cats and for the treatment of chronic pain and inflammation in dogs.
Carprox is presented as a palatable tablet for dogs in three sizes - 20 mg, 50 mg and 100 mg. An injectable 50 mg/ml solution for dogs and cats has also been launched (in bottles of 20ml).
Virbac Marketing Manager for Companion Animals Simon Boulton MRCVS said: "We launched our meloxicam-based solution for acute and chronic pain, Inflacam, in 2013. With the arrival of Carprox Vet, we are now able to offer vets a carprofen-based alternative for added flexibility and choice. We are delighted to add it to our product range and are proud to say that Virbac now offers one of the widest ranges of products for the treatment of small animals in the UK."
Domingo, pictured on the left with Southfields clinical director Henry L’Eplattenier, will join the Essex referral centre as head of cardiopulmonary service at the start of February.
After qualifying in Zaragoza in his native Spain, Domingo completed an internship and several years in practice in the UK, before joining the University of Bristol small animal hospital as a resident.
He then completed a three-year training programme in small animal internal medicine, followed by a four-year programme in cardiology to become an RCVS diplomate and specialist in veterinary cardiology and small animal internal medicine (ECVIM).
After being appointed as head of cardiology and respiratory medicine at Bristol, Domingo joined Dick White Referrals before his move to Southfields.
Domingo said: "I’m delighted to be joining such a progressive and forward-thinking practice as Southfields. It is clear everyone at the practice is dedicated to continuing its growth and dedication to providing the highest possible level of care."
Southfields’ operations manager Daniel Hogan said: "The arrival of Domingo adds another hugely talented specialist to our growing team of experts. He is, without doubt, at the top of his profession and his passion and dedication are traits which will fit perfectly at Southfields as we continue to grow."
Domingo is also a visiting lecturer in cardiology and respiratory medicine at the Catholic University of Valencia, while he is an active clinical researcher and has published widely in many areas of cardiology and respiratory medicine. His areas of special interest are arrhythmias and interventional cardiology.
For more information about Southfields Veterinary Specialists, go to www.southfields.co.uk.
Reporter Andy Davies spoke to Charlotte Debbaut MRCVS, a veterinary surgeon from Belgium working at the Tindale Veterinary Practice in Gloucestershire, where there are 13 vets with eight different nationalities. He also interviewed Matthew Pugh MRCVS and Ovidiu Oltean MRCVS from Belmont Veterinary Centre, a mixed practice in Hereford which employs five foreign nationals out of a team of 13 veterinary surgeons.
Finally, he talked to John Blackwell MRCVS at Brownlow Veterinary Group in Shropshire, where Brexit had already caused a Croatian member of his team to refuse a permanent position and return to Ireland.
Congratulations to the RCVS and BVA press offices, who will have been hard at work behind the scenes.
See: https://www.channel4.com/news/brexit-affecting-vet-recruitment
Ian graduated from the University of Liverpool and gained his PhD from the University of Glasgow. He gained both the UK and European Diplomas in Small Animal Medicine at the University of Cambridge and is a Royal College of Veterinary Surgeons and European Recognised Specialist in Small Animal Medicine. He returned to Glasgow University in 1998 and has been the Professor of Small Animal Medicine since 2009.
Ian has published in the fields of infectious diseases, endocrinology and neurology but is interested in all aspects of small animal medicine. In 2015 he was awarded the BSAVA Woodrow Award for his contribution to small animal medicine. In 2016 he became of Fellow of the RCVS, thereby becoming a jolly good fellow Fellow of the RCVS, or JGFFRCVS for short.
Professor Ramsey has served BSAVA as a regional secretary, member of several committees and chair of Petsavers and Scientific. He is probably best known as the editor of four editions of the BSAVA Small Animal Formulary.
The Presidential handover usually takes place at BSAVA Congress but was delayed this year given the cancellation of the April event due to coronavirus.
Ian says that during his Presidency, he intends to promote and enhance the digital offering of the Association to BSAVA members coping with the pandemic. He will also oversee changes to BSAVA congress with a more interactive approach to training; shortened, more focussed lectures and greater integration between the exhibition, the scientific content, and the social events.
Ian said: “At this time of great uncertainty in the profession, my focus will be on providing BSAVA members with the scientific information and clinical training that they need, in a suitable form. Clinical skills and science lie at the heart of being a good vet and BSAVA members get access to a huge range of cheap or free resources in these areas to help them in their careers. Congress 2021 will be evolving as a vital part of this effort and I am looking forward to welcoming everyone to Manchester during the last week of March 2021."
Charlie says that uniquely, the company offers feedback about samples submitted, with the aim of teaching veterinary staff the skills needed to interpret future samples themselves.
Cytovet is aimed at nurses and new grads who want to improve their cytology skills, vets who don’t have time to look at their own samples or have a tricky case they would like an additional opinion on, and those vets whose clients can’t afford the prices the big labs quote.
Charlie said: "I’m a vet with 16 years of clinical experience and a certAVP which focussed on small animal medicine and clinical pathology.
"I currently work in first opinion charity practice and have examined thousands of cytology samples over the years.
"I have been writing cytology reports for the practices I have worked for since 2012.
"I believe all vets and nurses should have the basic microscope skills required to help make more informed decisions for their patients, particularly in a world of escalating veterinary costs and antimicrobial resistance.
"I can examine both digital images and posted slides using a top-of-the-range trinocular digital microscope.
"All you need to do is submit the patient information and slides to me (digital images or actual slides) via my website and I will provide you with a report within 3-5 days."
Urgent turnaround is also available.
www.cytovet.co.uk
John Davies and Tom Lonsdale MsRCVS both objected to edits made by the College to their candidate statements.
Mr Davies explained in his statement how he'd been subject to "bewildering, unfounded and damaging allegations" from two veterinary nurses, one of which he says resulted in his dismissal from a practice at which he was a partner. He went on to explain how, in addition to taking the dismissal case to an employment tribunal and winning, he had also raised concerns with the College about the nurses who'd made the allegations against him. Mr Davies outlined the way he felt that the RCVS mismanaged his case and how that had driven him to stand for Council to try and address the grave concerns he now had about the governance of the profession. However, the Returning Officer redacted the details on the grounds that they were considered to be defamatory and/or factually misleading.
The main grounds for Mr Lonsdale’s challenge was that the election had been furthered by corrupt practices, namely undue influence (all in terms of the Misrepresentation of the People Act 1983). In addition, the Returning Officer edited Mr Lonsdale’s candidate statement before circulation to the electorate, refusing to include hypertext links and removing references that the Returning Officer believed to be defamatory. The Returning Officer also declined to publish his ‘Quiz the candidates’ video on the RCVS website and/or YouTube channel when requests to make minor amendments considered defamatory were refused.
Both challenges were lodged with the RCVS last July, after which the College set up a Challenge Committee in accordance with the election challenge procedure, approved by Privy Council. It comprised three members of Council nominated by RCVS President Stephen May.
Sitting with one of the RCVS Legal Assessors – Mr Richard Price OBE QC – the Challenge Committee was required to decide whether to declare the election void, based on whether the alleged irregularity in question rendered the election substantially not in accordance with the RCVS Council Election Scheme, or that the irregularity concerned significantly affected the result of the election (in which Mr Lonsdale and Mr Davies came 15th and 16th respectively out of 16 candidates).
Following written submissions from both the RCVS and Mr Davies, the Challenge Committee dismissed Mr Davies’s challenge, stating that there was no irregularity in the conduct of the election on the part of the Returning Officer, and that there was no valid basis for challenging the validity of the election.
The Challenge Committee (comprising the same members as for Mr Davies’s challenge) also dismissed Mr Lonsdale’s challenge, stating that it considered it to be 'totally devoid of merit'.
Prior to reaching this decisions, however, two preliminary challenges made by Mr Lonsdale were also considered and dismissed.
The first related to the members of the Challenge Committee, whom Mr Lonsdale argued should stand down on the basis of actual or apparent bias based on his allegations of connections with the pet food industry.
The Committee considered that a fair-minded and informed observer, having understood the facts, would conclude that the connection of committee members to the pet food industry were '….remote, indirect and, in the case of one panel member, virtually non-existent'.
Each committee member was satisfied that there was '…no real possibility of their judgement being distorted or influenced by any interest in, or links with, the pet food industry.'
The second challenge was to The Legal Assessor, who had been appointed to advise the Committee. Mr Lonsdale had alleged that Mr Price had displayed bias in the way that he had given advice to the Committee in relation to the challenge to the Committee membership. This was also dismissed.
Ceva Animal Health has renamed Tildren, its tiludronate-based bisphosphonate infusion for the treatment of bone spavin in horses, as Equidronate.
Tiludronate has been used to treat bone spavin and navicular disease in Europe for many years and was licensed for bone spavin in the UK in 2008. Ceva says trials published last year show that horses suffering lameness caused by bone spavin can show marked improvement following treatment with an Equidronate infusion, in combination with controlled exercise.
Bone spavin is a chronic aseptic osteoarthritis of the distal tarsal joints and is considered to be one of the most common forms of hindlimb lameness in the horse. Horses with bone spavin experience abnormal bone remodeling changes. According to the company, Equidronate helps to modulate the osteoclasts to help prevent excessive bone removal and give the osteoblasts a chance to catch up. This in combination with adjusting levels of exercise helps to harmonise the bone adaptation needed for the horse to perform its athletic duties.
In the trials one in four horses showed marked improvement; two in four showed improvement, which, when combined with other treatment, enabled the horse to resume former levels of activity and one in four horses showed no response.
Ceva Animal Health has produced a range of explanatory leaflets for horse owners on bone spavin, navicular disease and sacroiliac disease, as well as a helpful booklet detailing the discharge procedures for horses that have been treated with Equidronate.
For free copies and for further product information contact your Ceva sales representative, ring Ceva on 01494 781510 or visit the website at http://www.ceva.uk.com/
Elanco is highlighting new research which shows that using monensin in dairy cows at high risk of developing subclinical ketosis reduces curative antibiotic use by 25%.
According to the company, good herd management before calving is known to mitigate antimicrobial use in cows suffering from subclinical ketosis related conditions, but to date little research has quantified it.
The new research, by the University of Toulouse, was presented to leading cattle vets, academics and representatives of the pharmaceutical industry by veterinary cattle health specialist, Professor Didier Raboisson at the European Buiatrics Forum in Rome in October.1 It showed that using a monensin bolus in cows at high risk of getting subclinical ketosis led to a 25% reduction in antibiotics to treat and cure conditions associated with the metabolic condition.
Fiona Anderson MRCVS of Elanco said: "Responsible use of antimicrobials must be the target for veterinary medicine. Reducing use by whatever means could help improve the antimicrobial resistance situation. This new study shows that using monensin, which is available in the form of a Kexxtone bolus, is a powerful way to cut antibiotic use in the dairy herd. This is in addition to monensin already proven to be a valuable tool to reduce the risk of ketosis and subclinical ketosis and its associated losses in dairy herd productivity and profitability."
Subclinical ketosis is very common. It can affect up to 30% of cows in early lactation with a large variation between herds.2 It can be very costly for a dairy herd. A study from 2015 found that for a 100 cow herd with 30% ketosis, the direct and indirect costs can be around £10,416 or around £347 per affected cow.3
Cows affected by subclinical ketosis are at a higher risk of getting mastitis and metritis. They are also at higher risk of developing displaced abomasum, retained placenta and cystic ovaries and consequently face a higher culling risk. Subclinical ketosis also lowers milk production, reduces conception rates and lengthens calving intervals.4
If ketosis is an issue in a dairy herd, targeted administration of monensin in a Kexxtone bolus to cows at high risk of developing ketosis reduces the incidences of ketosis by 74%.6
The bolus is given three weeks before calving and provides coverage during the main risk period for the condition. Kexxtone uses monensin to improve rumen function and increase glucose delivery. This ultimately increases the energy available and buffers the dairy cow against the tendency to drop into negative energy balance.5
To make a big difference to clients’ profitability, Fiona encourages vets to not just consider the traditional nutritional intervention and the emergency treatment of ketosis cases, but to develop an effective strategy to highlight cows at risk of subclinical ketosis and to take targeted preventative action. She said: "Vets who can offer positive interventions to subclinical ketosis and its associated losses in the dairy herd are going to be increasingly important to their clients’ herd health planning."
References:
Clive Elwood, Ian Battersby, Laurent Garosi, Nat Whitley and David Gould have all become Fellows for Meritorious Contributions to Clinical Practice. Meanwhile, Jerry Davies, founder of Davies Veterinary Specialists, has become a Fellow for Meritorious Contributions to the Profession.
Whilst the decision has been welcomed by the BVA and leading animal charities, it has not been entirely free of controversy. According to various reports, the Press Association has seen a letter from Defra to the Royal Veterinary College in February this year, which said the scientific studies it had commissioned were 'not strong enough to support a ban'.
Talking to the BBC, Ian Gregory, a lobbyist for pet collar manufacturers said that charities had also exaggerated the shock delivered by the collars, which at typically one millijoule is 1000 times less than cattle fencing. He argued that: "The anecdotal problems reported with pet collars can be resolved by product standards rather than by banning a proven technology".
The government has stopped short of banning invisible fencing systems which can keep pets away from roads, saying that the devices are particularly useful for cat owners and animals often respond well to invisible fencing and quickly learn to stay within a boundary without receiving a static pulse.
BVA President John Fishwick said: "As we review the latest evidence on the welfare impact of pulse pet containment fences, we would like to see them covered by a code of practice, as well as the regulation of the sale of these devices and manufacturer’s instructions, to ensure that the potential adverse effects of use are highlighted to animal owners and consumers."
Photo: Shutterstock
The current strain of bluetongue emerged in the Netherlands in 2023 and spread rapidly, infecting over 5,000 livestock farms.
Infection of livestock with this serotype of the virus can result in severe clinical signs and high mortality rates1, significantly impacting animal health, and farming communities.
Bultavo 3 is an inactivated injectable vaccine indicated for the active immunisation against BTV-3.
Boehringer says that in sheep, Bultavo 3 has been shown to significantly reduce viraemia and prevent mortality and clinical signs associated with BTV-3 infection.
Onset of immunity occurs three weeks after administration of a single 1ml subcutaneous dose in sheep.
In cattle, two 1ml intramuscular doses are required, at a three-week interval.
Findlay MacBean, Head of Livestock, UK and Ireland at Boehringer Ingelheim, said: “It’s great news that we can support farmers and authorities in their fight against bluetongue with our new BTV-3 vaccine, Bultavo 3.
"As we have seen across Europe, and now in the UK, BTV can spread rapidly and causes considerable stress to farmers because of the significant financial impact on those affected.
The availability of Bultavo 3 means future BTV-3 outbreaks can be suppressed, helping farmers protect not only their herds, but also their livelihoods.” Oli Maxwell, BVSc BSc(Hons) MVM DipECBHM, RCVS Recognised Specialist in Cattle Health and Production and Clinical Director of Green Counties Vets said: “Farmers are justifiably concerned about BTV-3 and its incursion into the UK again this year.
"Reports from colleagues on the continent regarding the severity of clinical signs, especially in sheep are worrying.
"We have seen a huge increase in clients asking about the disease, progress on a vaccine and what this may mean for animal movements at a critical time of year.
"The availability of a safe and effective vaccine as a critical tool against a disease that we can’t reasonably prevent with biosecurity measures will be a welcome development for many.”
To manage supply and demand, use of the product will initially be subject to geographical restriction with vaccination permitted in high-risk English counties: Norfolk, Suffolk, Essex, Kent and East Sussex.
Reference:
The charity, which was set up over 120 years ago, says the number of calls and emails it gets from industry professionals seeking help has increased 500% over the last 5 years; it has received more than 1,500 calls and emails over the past 12 months.
Lynne Hill, Chief Executive of Linnaeus said: "The veterinary industry is fast-paced and, at times, an extremely stressful environment, so the support on offer from Vetlife is particularly valuable and its worth is demonstrated by the significant increase in contact being made to it.
"We hope this donation will help Vetlife continue to provide the excellent service and support they have given to vets and nurses for so long."
Vetlife President Geoff Little said: "This donation from the Linnaeus Group is extremely generous. We have seen a dramatic rise in calls and emails to the service over recent years. So much so, we have recruited additional volunteers to cope with the additional contacts. It’s extremely gratifying to see the number of volunteers who are so willing to put something back into their profession and to help others.
"At Vetlife, we provide support in the shape of three core services, which are the Vetlife Helpline, which provides independent, confidential support 24/7, 365 days a year; Health Support, run by mental health professionals; and Financial Support, which provides assistance to vets or their dependents who find themselves in difficulty.
"This support from Linnaeus will help us to bridge the gap as the need for support continues to grow."
Anyone who needs support can contact the Vetlife Helpline on 0303 040 2551 or anonymously via www.vetlife.org.uk.
Photo: Vetlife President Geoff Little receives the £60,000 donation from Lynn Hill at Linnaeus.